A living evidence approach to variants of concern (VOC) and COVID-19 vaccine effectiveness

Given the continued evolution of the pandemic, updated information is crucial for guiding policy decisions and prioritizing research efforts. This living review evaluates the effectiveness of WHO-approved COVID-19 vaccines (Pfizer–BioNTech, Moderna, Oxford–AstraZeneca, and Janssen) in protecting against Long Covid outcomes caused by variants of concern in adults.

Protocol: https://www.sciencedirect.com/science/article/pii/S0264410X23010654?via%3Dihub

Infographic: https://www.ksau.ca/ve-voc-long-covid-infographic

Immunological Dashboard: https://www.ksau.ca/ve-voc-immunological-dashboard-1